4-6694007-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_005980.3(S100P):c.75G>A(p.Thr25Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0027 in 1,613,992 control chromosomes in the GnomAD database, including 96 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.014 ( 45 hom., cov: 33)
Exomes 𝑓: 0.0015 ( 51 hom. )
Consequence
S100P
NM_005980.3 synonymous
NM_005980.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0540
Genes affected
S100P (HGNC:10504): (S100 calcium binding protein P) The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21; however, this gene is located at 4p16. This protein, in addition to binding Ca2+, also binds Zn2+ and Mg2+. This protein may play a role in the etiology of prostate cancer. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 4-6694007-G-A is Benign according to our data. Variant chr4-6694007-G-A is described in ClinVar as [Benign]. Clinvar id is 767948.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.054 with no splicing effect.
BA1
GnomAdExome4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0514 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0139 AC: 2120AN: 152224Hom.: 45 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
2120
AN:
152224
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00387 AC: 971AN: 251022 AF XY: 0.00273 show subpopulations
GnomAD2 exomes
AF:
AC:
971
AN:
251022
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00153 AC: 2239AN: 1461650Hom.: 51 Cov.: 31 AF XY: 0.00125 AC XY: 912AN XY: 727138 show subpopulations
GnomAD4 exome
AF:
AC:
2239
AN:
1461650
Hom.:
Cov.:
31
AF XY:
AC XY:
912
AN XY:
727138
Gnomad4 AFR exome
AF:
AC:
1789
AN:
33476
Gnomad4 AMR exome
AF:
AC:
89
AN:
44718
Gnomad4 ASJ exome
AF:
AC:
0
AN:
26128
Gnomad4 EAS exome
AF:
AC:
1
AN:
39700
Gnomad4 SAS exome
AF:
AC:
8
AN:
86256
Gnomad4 FIN exome
AF:
AC:
0
AN:
53310
Gnomad4 NFE exome
AF:
AC:
139
AN:
1111910
Gnomad4 Remaining exome
AF:
AC:
201
AN:
60386
Heterozygous variant carriers
0
106
212
319
425
531
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0139 AC: 2125AN: 152342Hom.: 45 Cov.: 33 AF XY: 0.0135 AC XY: 1006AN XY: 74492 show subpopulations
GnomAD4 genome
AF:
AC:
2125
AN:
152342
Hom.:
Cov.:
33
AF XY:
AC XY:
1006
AN XY:
74492
Gnomad4 AFR
AF:
AC:
0.04873
AN:
0.04873
Gnomad4 AMR
AF:
AC:
0.00391952
AN:
0.00391952
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.000205773
AN:
0.000205773
Gnomad4 OTH
AF:
AC:
0.0118259
AN:
0.0118259
Heterozygous variant carriers
0
101
201
302
402
503
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
15
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 24, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at